| Organism name | Escherichia coli K12 |
|---|---|
| Genus | Escherichia |
| Family | Enterobacteriaceae |
| Kingdom |
| Linked NCBI taxonomy name | Escherichia coli K-12 |
|---|---|
| Linked NCBI taxonomy ID | 83333 |
| Linked level | no rank |
| Family in NCBI taxonomy | Enterobacteriaceae |
|---|---|
| ID | 543 |
| Kingdom (Superkingdom) in NCBI taxonomy | Bacteria |
|---|---|
| ID | 2 |
| Plant class | |
|---|---|
| ID |
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
|
C00001173
|
Sorbitol
/ D-Sorbitol / D-Glucitol / (-)-Sorbitol |
CHEMBL16105
CHEMBL689 CHEMBL1682 CHEMBL1735282 CHEMBL1773904 |
D013012
|
101 / 49 / 42 | 8 / 5 | No. 630 |
|
|
|
C00007391
|
alpha-D-Galactose 1-phosphate
|
CHEMBL291890
CHEMBL67622 CHEMBL1159526 CHEMBL1741538 |
C029973
|
6 / 2 / 3 | 1 / 1 | No. 713 |
|
|
|
C00019673
|
cGMP
/ Cyclic GMP / 3',5'-Cyclic GMP / Guanosine 3',5'-cyclic monophosphate |
CHEMBL68554
CHEMBL395336 |
D006152
|
9 / 3 / 2 | 11 / 7 | No. 1201 |
|
|
|
C00007445
|
Adenosine 5'-phosphosulfate
|
CHEMBL578658
CHEMBL572546 |
D000250
|
No. 1201 |
|
|||
|
C00001396
|
L-Tryptophan
|
CHEMBL54976
CHEMBL292303 CHEMBL484901 |
49 / 41 / 39 | No. 1432 | No. 4 |
|
||
|
C00019660
|
Xanthine
|
CHEMBL1424
|
D019820
|
8 / 6 / 2 | 4 / 2 | No. 2266 | No. 12 |
|
|
C00007287
|
3-Phosphoserine
|
CHEMBL284377
CHEMBL1418244 |
C046162
|
20 / 11 / 11 | No. 2301 |
|
||
|
C00007385
|
O-Phospho-L-homoserine
|
No. 2301 |
|
|||||
|
C00007469
|
L-Aspartate 4-semialdehyde
|
CHEMBL404100
|
No. 2595 |
|
||||
|
C00007396
|
XMP
/ Xanthosine 5'-monophosphate |
CHEMBL1206243
|
C011141
|
No. 2692 | No. 12 |
|
||
|
C00019675
|
2-Oxobutyric acid
/ 2-Ketobutyric acid / 2-Oxobutanoic acid / alpha-Ketobutyric acid |
CHEMBL171246
|
C005087
|
1 / 0 / 0 | 1 / 0 | No. 2782 |
|
|
|
C00007311
|
UMP
/ Uridine 5'-phosphate |
CHEMBL214393
CHEMBL603336 |
D014542
|
4 / 3 / 1 | No. 3259 |
|
||
|
C00019637
|
dTMP
/ Thymidine 5'-phosphate |
CHEMBL394429
|
D013938
|
3 / 0 / 1 | No. 3259 |
|
||
|
C00001386
|
L-Phenylalanine
|
CHEMBL25080
CHEMBL301523 CHEMBL379630 |
27 / 18 / 14 | No. 3303 |
|
|||
|
C00019655
|
AIR (nucleotide)
/ Aminoimidazole ribonucleotide / 5-Amino-1-beta-D-ribofuranosyl-5'-(dihydrogen phosphate)-imidazole |
C024828
|
No. 3393 |
|
||||
|
C00001366
|
L-Homoserine
|
CHEMBL11722
|
No. 3420 |
|
||||
|
C00019688
|
L-Arginosuccinic acid
/ L-Argininosuccinic acid |
D001125
|
No. 3841 |
|
||||
|
C00001337
|
gamma-Aminobutyric acid
|
CHEMBL96
|
D005680
|
50 / 36 / 27 | 21 / 17 | No. 3932 |
|
|
|
C00007229
|
Adenylosuccinate
/ Adenylsuccinic acid / Adenylosuccinic acid |
CHEMBL1812061
|
C052755
|
1 / 0 / 0 | No. 4121 |
|
||
|
C00001374
|
L-isoleucine
|
CHEMBL297800
CHEMBL56053 CHEMBL1233584 CHEMBL1720399 CHEMBL1867019 CHEMBL1869615 |
4 / 2 / 0 | No. 4144 |
|
|||
|
C00007623
|
2-Ketoisovalerate
/ alpha-Ketoisovalerate / 3-Methyl-2-oxobutanoic acid |
CHEMBL146554
|
C001505
|
1 / 0 / 0 | No. 5279 |
|
||
|
C00019678
|
2,3-Dihydroxyisovaleric acid
/ 2,3-Dihydroxy-isovaleric acid |
C027749
|
No. 5300 |
|
||||
|
C00007607
|
4-Amino-2-methyl-5-phosphomethylpyrimidine
/ 4-Amino-5-phosphomethyl-2-methylpyrimidine |
No. 5373 |
|
|||||
|
C00007373
|
Uroporphyrinogen III
|
No. 5446 |
|
|||||
|
C00007583
|
Orotidine 5'-phosphate
|
CHEMBL610606
CHEMBL1207358 |
No. 6439 |
|
||||
|
C00001394
|
L-Threonine
|
CHEMBL30037
CHEMBL291747 CHEMBL59238 CHEMBL319354 CHEMBL555743 CHEMBL1734340 |
4 / 11 / 10 | No. 6720 |
|
|||
|
C00007610
|
4-methyl-5-(2hydroxyethyl)thiazole
/ 4-Metyl-5-(beta-hydroxyethyl)thiazole |
CHEMBL1236482
|
C012572
|
No. 7034 | No. 5 |
|
||
|
C00019621
|
O-Succinyl-L-homoserine
|
No. 7675 |
|
|||||
|
C00019682
|
4-Oxobutanoic acid
/ Succinaldehydic acid / beta-Formylpropionic acid |
C009338
|
2 / 0 | No. 7950 |
|
|||
|
C00007471
|
L-4-Aspartyl phosphate
|
No. 8177 |
|
|||||
|
C00019632
|
Prephenic acid
|
C005550
|
No. 8339 |
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00001173 C00001337 C00001386 C00001396 C00007287 C00007391 | 0 / 1 |
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00001173 C00001337 C00001386 C00001396 C00007287 C00007391 | 1 / 0 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00001173 C00001337 C00001386 C00001396 C00007287 C00007391 | 1 / 1 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00001173 C00001337 C00001386 C00001396 C00007287 C00007391 | 0 / 0 |
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00001173 C00001337 C00001374 C00001394 C00001396 C00007287 | 0 / 0 |
| P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00001337 C00001374 C00001386 C00001396 C00007287 C00007311 | 2 / 0 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00001173 C00001337 C00001386 C00001396 C00007287 C00007391 | 0 / 1 |
| P10828 | Thyroid hormone receptor beta | NR1A2 | C00001337 C00001386 C00007287 C00019660 | 3 / 1 |
| P00918 | Carbonic anhydrase 2 | Lyase | C00001173 C00001386 C00001396 C00007287 | 1 / 2 |
| P02545 | Prelamin-A/C | Unclassified protein | C00001173 C00001337 C00001394 C00001396 | 11 / 10 |
| P22748 | Carbonic anhydrase 4 | Lyase | C00001386 C00001396 C00007287 | 1 / 1 |
| P00915 | Carbonic anhydrase 1 | Lyase | C00001386 C00001396 C00007287 | 0 / 0 |
| Q05BR4 | SLC16A10 protein | Unclassified protein | C00001337 C00001386 C00001396 | 0 / 0 |
| P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00001386 C00001396 C00007287 | 0 / 0 |
| P54132 | Bloom syndrome protein | Enzyme | C00001337 C00001396 C00007287 | 1 / 2 |
| O75496 | Geminin | Unclassified protein | C00001173 C00001337 C00001396 | 0 / 0 |
| Q16790 | Carbonic anhydrase 9 | Lyase | C00001386 C00001396 C00007287 | 0 / 1 |
| Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00001386 C00001396 | 0 / 0 |
| P43166 | Carbonic anhydrase 7 | Lyase | C00001386 C00001396 | 0 / 0 |
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00001386 C00001396 | 0 / 0 |
| Q7Z2H8 | Proton-coupled amino acid transporter 1 | Unclassified protein | C00001337 C00001374 | 0 / 0 |
| P03372 | Estrogen receptor | NR3A1 | C00001173 C00001386 | 1 / 1 |
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00001173 C00001386 | 0 / 0 |
| P07451 | Carbonic anhydrase 3 | Lyase | C00001386 C00001396 | 0 / 0 |
| P04150 | Glucocorticoid receptor | NR3C1 | C00001173 C00001386 | 0 / 1 |
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00001337 C00001396 | 1 / 2 |
| P05186 | Alkaline phosphatase, tissue-nonspecific isozyme | Enzyme | C00001386 C00001396 | 3 / 1 |
| P09923 | Intestinal-type alkaline phosphatase | Enzyme | C00001386 C00001396 | 0 / 0 |
| Q9UBT6 | DNA polymerase kappa | Enzyme | C00001374 C00001394 | 0 / 0 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00001396 C00007287 | 0 / 0 |
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00001337 C00001396 | 0 / 0 |
| O15427 | Monocarboxylate transporter 4 | Unclassified protein | C00007623 C00019675 | 0 / 0 |
| Q9Y263 | Phospholipase A-2-activating protein | Unclassified protein | C00001386 C00001396 | 0 / 0 |
| P16473 | Thyrotropin receptor | Glycohormone receptor | C00001337 C00001396 | 3 / 2 |
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00001173 C00001337 | 0 / 0 |
| P39748 | Flap endonuclease 1 | Enzyme | C00001173 C00001396 | 0 / 0 |
| Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00001337 C00001396 | 0 / 0 |
| O43570 | Carbonic anhydrase 12 | Lyase | C00001386 C00001396 | 1 / 2 |
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00001394 C00007287 | 0 / 0 |
| Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00001386 C00001396 | 0 / 0 |
| P23280 | Carbonic anhydrase 6 | Lyase | C00001386 C00001396 | 0 / 0 |
| P29274 | Adenosine receptor A2a | Adenosine receptor | C00001173 C00019660 | 0 / 0 |
| P10323 | Acrosin | S1A | C00001173 C00007391 | 0 / 0 |
| Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00001173 C00001337 | 1 / 1 |
| Q07343 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | PDE_4B | C00019660 | 0 / 0 |
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00001173 | 0 / 0 |
| P04183 | Thymidine kinase, cytosolic | Enzyme | C00019637 | 0 / 1 |
| P02768 | Serum albumin | Secreted protein | C00001396 | 0 / 0 |
| P25098 | Beta-adrenergic receptor kinase 1 | Bark | C00019673 | 0 / 0 |
| P08183 | Multidrug resistance protein 1 | drug | C00001173 | 1 / 0 |
| P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00001173 | 0 / 0 |
| P06241 | Tyrosine-protein kinase Fyn | Src | C00001173 | 0 / 0 |
| Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00001173 | 0 / 0 |
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00001173 | 0 / 0 |
| Q14831 | Metabotropic glutamate receptor 7 | Metabotropic glutamate receptor | C00007287 | 0 / 0 |
| P24046 | Gamma-aminobutyric acid receptor subunit rho-1 | GABA-A rho | C00001337 | 0 / 0 |
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00001173 | 1 / 0 |
| Q9HAW7 | UDP-glucuronosyltransferase 1-7 | Enzyme | C00001396 | 0 / 0 |
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00001173 | 1 / 8 |
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00001173 | 2 / 0 |
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00001173 | 0 / 0 |
| P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00001173 | 0 / 0 |
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00001173 | 0 / 0 |
| Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00001173 | 0 / 0 |
| P35367 | Histamine H1 receptor | Histamine receptor | C00001173 | 0 / 0 |
| P25021 | Histamine H2 receptor | Histamine receptor | C00001173 | 0 / 0 |
| P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00001173 | 0 / 0 |
| P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00001173 | 1 / 1 |
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00001173 | 0 / 0 |
| P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00001173 | 1 / 0 |
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00001173 | 1 / 1 |
| P14867 | Gamma-aminobutyric acid receptor subunit alpha-1 | GABA-A alpha | C00001337 | 1 / 1 |
| P48065 | Sodium- and chloride-dependent betaine transporter | Betaine and GABA Na-symporter | C00001337 | 0 / 0 |
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00001173 | 0 / 1 |
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00001173 | 0 / 0 |
| Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00001396 | 0 / 0 |
| Q15077 | P2Y purinoceptor 6 | Purine receptor | C00007311 | 0 / 0 |
| P23415 | Glycine receptor subunit alpha-1 | GLR alpha | C00001337 | 1 / 1 |
| P42858 | Huntingtin | Unclassified protein | C00001396 | 1 / 1 |
| P29973 | cGMP-gated cation channel alpha-1 | Unclassified protein | C00019673 | 1 / 1 |
| Q16280 | Cyclic nucleotide-gated olfactory channel | Unclassified protein | C00019673 | 0 / 0 |
| O15439 | Multidrug resistance-associated protein 4 | Unclassified protein | C00019673 | 0 / 0 |
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00001173 | 0 / 0 |
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00001173 | 0 / 0 |
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00001173 | 0 / 0 |
| P30988 | Calcitonin receptor | Calcitonin receptor | C00001173 | 0 / 0 |
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00001173 | 1 / 0 |
| P41143 | Delta-type opioid receptor | Opioid receptor | C00001173 | 0 / 0 |
| P46098 | 5-hydroxytryptamine receptor 3A | NS | C00001337 | 0 / 0 |
| Q92731 | Estrogen receptor beta | NR3A2 | C00001173 | 0 / 1 |
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00001173 | 0 / 0 |
| P25101 | Endothelin-1 receptor | Endothelin receptor | C00001173 | 0 / 0 |
| P30411 | B2 bradykinin receptor | Bradykinin receptor | C00001173 | 0 / 0 |
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00001173 | 1 / 0 |
| Q16281 | Cyclic nucleotide-gated cation channel alpha-3 | Unclassified protein | C00019673 | 1 / 1 |
| P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00001173 | 0 / 0 |
| P08311 | Cathepsin G | S1A | C00001173 | 0 / 0 |
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00001173 | 1 / 0 |
| P03956 | Interstitial collagenase | M10A | C00001173 | 0 / 1 |
| P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00001173 | 0 / 0 |
| O15245 | Solute carrier family 22 member 1 | Drug uniporter | C00001173 | 0 / 0 |
| P11172 | Uridine 5'-monophosphate synthase | Enzyme | C00007311 | 1 / 1 |
| Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00001173 | 0 / 0 |
| P11308 | Transcriptional regulator ERG | Unclassified protein | C00001337 | 1 / 2 |
| P14780 | Matrix metalloproteinase-9 | M10A | C00001173 | 2 / 2 |
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00001173 | 0 / 0 |
| P23919 | Thymidylate kinase | Enzyme | C00019637 | 0 / 0 |
| P04818 | Thymidylate synthase | Transferase | C00019637 | 0 / 0 |
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00001173 | 2 / 0 |
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00001173 | 0 / 0 |
| P14679 | Tyrosinase | Oxidoreductase | C00001386 | 4 / 2 |
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00001173 | 0 / 0 |
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00001173 | 2 / 0 |
| P80404 | 4-aminobutyrate aminotransferase, mitochondrial | Transferase | C00001337 | 1 / 1 |
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00001173 | 5 / 9 |
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00001173 | 1 / 0 |
| P21452 | Substance-K receptor | Neurokinin receptor | C00001173 | 0 / 0 |
| Q9UBS5 | Gamma-aminobutyric acid type B receptor subunit 1 | GABA-B receptor | C00001337 | 0 / 0 |
| P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00001173 | 0 / 0 |
| P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00001173 | 3 / 0 |
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00001173 | 0 / 0 |
| P36544 | Neuronal acetylcholine receptor subunit alpha-7 | CHRN alpha | C00001337 | 0 / 0 |
| P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00001173 | 1 / 0 |
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00001173 | 0 / 0 |
| P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00001173 | 2 / 1 |
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00001173 | 0 / 0 |
| P17252 | Protein kinase C alpha type | Alpha | C00001173 | 0 / 0 |
| Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00001396 | 1 / 1 |
| Q01453 | Peripheral myelin protein 22 | Unclassified protein | C00001396 | 5 / 2 |
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00001337 | 0 / 0 |
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00001173 | 0 / 0 |
| P29466 | Caspase-1 | C14 | C00001173 | 0 / 0 |
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00001173 | 1 / 0 |
| P22303 | Acetylcholinesterase | Hydrolase | C00001173 | 1 / 0 |
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00001173 | 0 / 0 |
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00001173 | 0 / 0 |
| P35372 | Mu-type opioid receptor | Opioid receptor | C00001173 | 0 / 0 |
| Q04609 | Glutamate carboxypeptidase 2 | M28B | C00007287 | 0 / 0 |
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00001173 | 0 / 0 |
| P25103 | Substance-P receptor | Neurokinin receptor | C00001173 | 0 / 0 |
| P25105 | Platelet-activating factor receptor | PAF receptor | C00001173 | 0 / 0 |
| P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00001173 | 0 / 0 |
| Q14833 | Metabotropic glutamate receptor 4 | Metabotropic glutamate receptor | C00007287 | 0 / 0 |
| P48775 | Tryptophan 2,3-dioxygenase | Enzyme | C00001396 | 0 / 0 |
| P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00001396 | 0 / 0 |
| Q16773 | Kynurenine--oxoglutarate transaminase 1 | Enzyme | C00001396 | 0 / 0 |
| Q9Y2T3 | Guanine deaminase | Enzyme | C00019660 | 0 / 0 |
| P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00001173 | 0 / 0 |
| Q9UNA4 | DNA polymerase iota | Enzyme | C00001396 | 0 / 0 |
| Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | C00001337 | 1 / 0 |
| P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00001173 | 0 / 0 |
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00001396 | 4 / 3 |
| Q99549 | M-phase phosphoprotein 8 | Unclassified protein | C00001396 | 0 / 0 |
| Q6DHV7 | Adenosine deaminase-like protein | Enzyme | C00007229 | 0 / 0 |
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00001173 | 0 / 0 |
| P30085 | UMP-CMP kinase | Enzyme | C00007311 | 0 / 0 |
| P00492 | Hypoxanthine-guanine phosphoribosyltransferase | Enzyme | C00019660 | 2 / 1 |
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00001173 | 1 / 1 |
| P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00001173 | 0 / 0 |
| P30542 | Adenosine receptor A1 | Adenosine receptor | C00001173 | 0 / 0 |
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00001173 | 0 / 0 |
| P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00001173 | 1 / 1 |
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00001173 | 0 / 0 |
| P06239 | Tyrosine-protein kinase Lck | Src | C00001173 | 0 / 1 |
| P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00001173 | 0 / 0 |
| P08254 | Stromelysin-1 | M10A | C00001396 | 1 / 0 |
| P08246 | Neutrophil elastase | S1A | C00001173 | 2 / 1 |
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00001173 | 2 / 2 |
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00001173 | 0 / 3 |
| P30531 | Sodium- and chloride-dependent GABA transporter 1 | GABA | C00001337 | 0 / 0 |
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00007287 | 1 / 1 |
| O15440 | Multidrug resistance-associated protein 5 | Unclassified protein | C00019673 | 0 / 0 |
| O00255 | Menin | Unclassified protein | C00001396 | 2 / 5 |
| Q13951 | Core-binding factor subunit beta | Unclassified protein | C00001396 | 0 / 1 |
| Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00001396 | 1 / 4 |
| Q08493 | cAMP-specific 3',5'-cyclic phosphodiesterase 4C | PDE_4C | C00019660 | 0 / 0 |
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00001173 | 0 / 0 |
| P27815 | cAMP-specific 3',5'-cyclic phosphodiesterase 4A | PDE_4A | C00019660 | 0 / 0 |
| Q08499 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | PDE_4D | C00019660 | 1 / 0 |
| Q9UN88 | Gamma-aminobutyric acid receptor subunit theta | GABA-A theta | C00001337 | 0 / 0 |
| P28472 | Gamma-aminobutyric acid receptor subunit beta-3 | GABA-A beta | C00001337 | 1 / 0 |
| P48169 | Gamma-aminobutyric acid receptor subunit alpha-4 | GABA-A alpha | C00001337 | 0 / 0 |
| O14764 | Gamma-aminobutyric acid receptor subunit delta | GABA-A delta | C00001337 | 1 / 1 |
| P31644 | Gamma-aminobutyric acid receptor subunit alpha-5 | GABA-A alpha | C00001337 | 0 / 0 |
| Q99928 | Gamma-aminobutyric acid receptor subunit gamma-3 | GABA-A gamma | C00001337 | 0 / 0 |
| P78334 | Gamma-aminobutyric acid receptor subunit epsilon | GABA-A epsilon | C00001337 | 0 / 0 |
| Q8N1C3 | Gamma-aminobutyric acid receptor subunit gamma-1 | GABA-A gamma | C00001337 | 0 / 0 |
| P34903 | Gamma-aminobutyric acid receptor subunit alpha-3 | GABA-A alpha | C00001337 | 0 / 0 |
| O00591 | Gamma-aminobutyric acid receptor subunit pi | GABA-A pi | C00001337 | 0 / 0 |
| P47870 | Gamma-aminobutyric acid receptor subunit beta-2 | GABA-A beta | C00001337 | 0 / 0 |
| P18507 | Gamma-aminobutyric acid receptor subunit gamma-2 | GABA-A gamma | C00001337 | 4 / 2 |
| P18505 | Gamma-aminobutyric acid receptor subunit beta-1 | GABA-A beta | C00001337 | 0 / 0 |
| Q16445 | Gamma-aminobutyric acid receptor subunit alpha-6 | GABA-A alpha | C00001337 | 0 / 0 |
| P47869 | Gamma-aminobutyric acid receptor subunit alpha-2 | GABA-A alpha | C00001337 | 1 / 0 |
| A8MPY1 | Gamma-aminobutyric acid receptor subunit rho-3 | GABA-A rho | C00001337 | 0 / 0 |
| P28476 | Gamma-aminobutyric acid receptor subunit rho-2 | GABA-A rho | C00001337 | 0 / 0 |
| P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | C00001173 | 0 / 0 |
| Q96J66 | ATP-binding cassette sub-family C member 11 | Unclassified protein | C00019673 | 1 / 0 |
| Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | C00001396 | 0 / 0 |
| Q13370 | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | PDE_3B | C00019673 | 0 / 0 |
| Q14432 | cGMP-inhibited 3',5'-cyclic phosphodiesterase A | PDE_3A | C00019673 | 0 / 0 |
| O75899 | Gamma-aminobutyric acid type B receptor subunit 2 | GABA-B receptor | C00001337 | 0 / 0 |
| P48066 | Sodium- and chloride-dependent GABA transporter 3 | GABA | C00001337 | 0 / 0 |
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 6566 | SLC16A1, HHF7, MCT, MCT1 | solute carrier family 16 (monocarboxylate transporter), member 1 |
C00019675
|
| 10327 | AKR1A1, ALDR1, ALR, ARM, DD3 | aldo-keto reductase family 1, member A1 (aldehyde reductase) (EC:1.1.1.2) |
C00019682
|
| 8574 | AKR7A2, AFAR, AFAR1, AFB1-AR1, AKR7 | aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) (EC:1.1.1.n11) |
C00019682
|
| 2584 | GALK1, GALK, GK1 | galactokinase 1 (EC:2.7.1.6) |
C00007391
|
| 18 | ABAT, GABA-AT, GABAT, NPD009 | 4-aminobutyrate aminotransferase (EC:2.6.1.19 2.6.1.22) |
C00001337
|
| 1138 | CHRNA5, LNCR2 | cholinergic receptor, nicotinic, alpha 5 (neuronal) |
C00001337
|
| 1140 | CHRNB1, ACHRB, CHRNB, CMS1D, CMS2A, SCCMS | cholinergic receptor, nicotinic, beta 1 (muscle) |
C00001337
|
| 2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00001337
|
| 2550 | GABBR1, GABABR1, GABBR1-3, GB1, GPRC3A, dJ271M21.1.1, dJ271M21.1.2 | gamma-aminobutyric acid (GABA) B receptor, 1 |
C00001337
|
| 9568 | GABBR2, GABABR2, GPR51, GPRC3B, HG20, HRIHFB2099 | gamma-aminobutyric acid (GABA) B receptor, 2 |
C00001337
|
| 2554 | GABRA1, ECA4, EJM, EJM5 | gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
C00001337
|
| 2555 | GABRA2 | gamma-aminobutyric acid (GABA) A receptor, alpha 2 |
C00001337
|
| 2557 | GABRA4 | gamma-aminobutyric acid (GABA) A receptor, alpha 4 |
C00001337
|
| 2558 | GABRA5 | gamma-aminobutyric acid (GABA) A receptor, alpha 5 |
C00001337
|
| 2559 | GABRA6 | gamma-aminobutyric acid (GABA) A receptor, alpha 6 |
C00001337
|
| 2560 | GABRB1 | gamma-aminobutyric acid (GABA) A receptor, beta 1 |
C00001337
|
| 2561 | GABRB2 | gamma-aminobutyric acid (GABA) A receptor, beta 2 |
C00001337
|
| 2562 | GABRB3, ECA5 | gamma-aminobutyric acid (GABA) A receptor, beta 3 |
C00001337
|
| 2563 | GABRD, EIG10, EJM7, GEFSP5 | gamma-aminobutyric acid (GABA) A receptor, delta |
C00001337
|
| 2564 | GABRE | gamma-aminobutyric acid (GABA) A receptor, epsilon |
C00001337
|
| 2566 | GABRG2, CAE2, ECA2, GEFSP3 | gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
C00001337
|
| 2571 | GAD1, CPSQ1, GAD, SCP | glutamate decarboxylase 1 (brain, 67kDa) (EC:4.1.1.15) |
C00001337
|
| 6529 | SLC6A1, GABATHG, GABATR, GAT1 | solute carrier family 6 (neurotransmitter transporter), member 1 |
C00001337
|
| 6538 | SLC6A11, GAT-3, GAT3, GAT4 | solute carrier family 6 (neurotransmitter transporter), member 11 |
C00001337
|
| 6540 | SLC6A13, GAT-2, GAT2, GAT3 | solute carrier family 6 (neurotransmitter transporter), member 13 |
C00001337
|
| 10257 | ABCC4, EST170205, MOAT-B, MOATB, MRP4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 |
C00019673
|
| 217 | ALDH2, ALDH-E2, ALDHI, ALDM | aldehyde dehydrogenase 2 family (mitochondrial) (EC:1.2.1.3) |
C00019673
|
| 5604 | MAP2K1, CFC3, MAPKK1, MEK1, MKK1, PRKMK1 | mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) |
C00019673
|
| 5605 | MAP2K2, CFC4, MAPKK2, MEK2, MKK2, PRKMK2 | mitogen-activated protein kinase kinase 2 (EC:2.7.12.2) |
C00019673
|
| 5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00019673
|
| 4878 | NPPA, ANF, ANP, ATFB6, CDD-ANF, PND | natriuretic peptide A |
C00019673
|
| 10846 | PDE10A, HSPDE10A | phosphodiesterase 10A (EC:3.1.4.35 3.1.4.17) |
C00019673
|
| 50940 | PDE11A, PPNAD2 | phosphodiesterase 11A (EC:3.1.4.35 3.1.4.17) |
C00019673
|
| 8654 | PDE5A, CGB-PDE, CN5A, PDE5 | phosphodiesterase 5A, cGMP-specific (EC:3.1.4.35) |
C00019673
|
| 5152 | PDE9A, HSPDE9A2 | phosphodiesterase 9A (EC:3.1.4.35) |
C00019673
|
| 6794 | STK11, LKB1, PJS, hLKB1 | serine/threonine kinase 11 (EC:2.7.11.1) |
C00019673
|
| 1977 | EIF4E, AUTS19, CBP, EIF4E1, EIF4EL1, EIF4F | eukaryotic translation initiation factor 4E |
C00001173
|
| 1978 | EIF4EBP1, 4E-BP1, 4EBP1, BP-1, PHAS-I | eukaryotic translation initiation factor 4E binding protein 1 |
C00001173
|
| 5602 | MAPK10, JNK3, JNK3A, PRKM10, SAPK1b, p493F12, p54bSAPK | mitogen-activated protein kinase 10 (EC:2.7.11.24) |
C00001173
|
| 6300 | MAPK12, ERK3, ERK6, P38GAMMA, PRKM12, SAPK-3, SAPK3 | mitogen-activated protein kinase 12 (EC:2.7.11.24) |
C00001173
|
| 1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) |
C00001173
|
| 9261 | MAPKAPK2, MAPKAP-K2, MK-2, MK2 | mitogen-activated protein kinase-activated protein kinase 2 (EC:2.7.11.1) |
C00001173
|
| 8569 | MKNK1, MNK1 | MAP kinase interacting serine/threonine kinase 1 (EC:2.7.11.1) |
C00001173
|
| 51035 | UBXN1, 2B28, SAKS1, UBXD10 | UBX domain protein 1 |
C00001173
|
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00019660
|
| 847 | CAT | catalase (EC:1.11.1.6) |
C00019660
|
| 7040 | TGFB1, CED, DPD1, LAP, TGFB, TGFbeta | transforming growth factor, beta 1 |
C00019660
|
| 7498 | XDH, XO, XOR | xanthine dehydrogenase (EC:1.17.1.4 1.17.3.2) |
C00019660
|
| OMIM | preferred title | UniProt |
|---|---|---|
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
| #216900 | Achromatopsia 2; achm2 |
Q16281
|
| #614613 | Acrodysostosis 2, with or without hormone resistance; acrdys2 |
Q08499
|
| #103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
| #203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
| #606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
| #103780 | Alcohol dependence |
P08172
P14416 P31645 P47869 |
| #612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
| #117800 | Apocrine gland secretion, variation in |
Q96J66
|
| #608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
| #210900 | Bloom syndrome; blm |
P54132
|
| #602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
| #300615 | Brunner syndrome |
P21397
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
| #614466 | Coronary heart disease, susceptibility to, 6; chds6 |
P08254
|
| #162800 | Cyclic neutropenia |
P08246
|
| #612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
| #607208 | Dravet syndrome |
P18507
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #237500 | Dubin-johnson syndrome; djs |
Q92887
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #607681 | Epilepsy, childhood absence, susceptibility to, 2; eca2 |
P18507
|
| #612269 | Epilepsy, childhood absence, susceptibility to, 5; eca5 |
P28472
|
| #613060 | Epilepsy, idiopathic generalized, susceptibility to, 10; eig10 |
O14764
|
| #611136 | Epilepsy, juvenile myoclonic, susceptibility to, 5; ejm5 |
P14867
|
| #615363 | Estrogen resistance; estrr |
P03372
|
| #612219 | Ewing sarcoma; es |
P11308
|
| #600274 | Frontotemporal dementia; ftd |
P10636
|
| #613163 | Gaba-transaminase deficiency |
P80404
|
| #613659 | Gastric cancer |
P04626
|
| #137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
| #604233 | Generalized epilepsy with febrile seizures plus, type 1; gefsp1 |
P18507
|
| #611277 | Generalized epilepsy with febrile seizures plus, type 3; gefsp3 |
P18507
|
| #231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
| #137800 | Glioma susceptibility 1; glm1 |
P04626
|
| #139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
| #143100 | Huntington disease; hd |
P42858
|
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #143860 | Hyperchlorhidrosis, isolated |
O43570
|
| #149400 | Hyperekplexia, hereditary 1; hkpx1 |
P23415
|
| #145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
| #603373 | Hyperthyroidism, familial gestational |
P16473
|
| #609152 | Hyperthyroidism, nonautoimmune |
P16473
|
| #145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
| #146300 | Hypophosphatasia, adult |
P05186
|
| #241510 | Hypophosphatasia, childhood |
P05186
|
| #241500 | Hypophosphatasia, infantile |
P05186
|
| #275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
| #612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
| #603932 | Intervertebral disc disease; idd |
P14780
|
| #300323 | Kelley-seegmiller syndrome |
P00492
|
| #300322 | Lesch-nyhan syndrome; lns |
P00492
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #613688 | Long qt syndrome 2; lqt2 |
Q12809
|
| #211980 | Lung cancer |
P00533
P04626 |
| #608516 | Major depressive disorder; mdd |
P08172
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| %300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
| #613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
| #131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
| #126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #159900 | Myoclonic dystonia |
P14416
|
| #162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
| #202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
| #601665 | Obesity |
P32245
|
| #164230 | Obsessive-compulsive disorder; ocd |
P31645
|
| #258900 | Orotic aciduria |
P11172
|
| #604715 | Orthostatic intolerance |
P23975
|
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
| #167000 | Ovarian cancer |
P04626
|
| #260540 | Parkinson-dementia syndrome |
P10636
|
| #613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
| #172700 | Pick disease of brain |
P10636
|
| #601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
| #607276 | Resting heart rate, variation in |
P08588
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
| #613756 | Retinitis pigmentosa 49; rp49 |
P29973
|
| #604906 | Schizophrenia 9; sczd9 |
P49798
|
| #181500 | Schizophrenia; sczd |
P49798
|
| #608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
| #609620 | Short qt syndrome 1; sqt1 |
Q12809
|
| #601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
| #601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
| #188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
| #274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
| #145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
| #190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
| #610379 | West nile virus, susceptibility to |
P51681
|
| #112100 | Yt blood group antigen |
P22303
|
| KEGG | name | UniProt |
|---|---|---|
| H00033 | Adrenal carcinoma |
O00255
(related)
|
| H00034 | Carcinoid |
O00255
(related)
|
| H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
| H00246 | Primary hyperparathyroidism |
O00255
(related)
|
| H01102 | Pituitary adenomas |
O00255
(related)
|
| H00783 | Febrile seizures |
O14764
(related)
P18507 (related) |
| H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
| H00021 | Renal cell carcinoma |
O43570
(marker)
Q16790 (marker) |
| H00194 | Lesch-Nyhan syndrome |
P00492
(related)
|
| H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
| H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
| H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
| H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
| H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) |
| H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
| H00042 | Glioma |
P00533
(related)
P00533 (marker) |
| H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
| H00436 | Osteopetrosis |
P00918
(related)
|
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) |
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
| H00005 | Chronic lymphocytic leukemia (CLL) |
P04183
(marker)
|
| H00019 | Pancreatic cancer |
P04626
(related)
|
| H00027 | Ovarian cancer |
P04626
(related)
|
| H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
| H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
| H00213 | Hypophosphatasia |
P05186
(related)
|
| H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
| H00079 | Asthma |
P07550
(related)
|
| H00100 | Neutropenic disorders |
P08246
(related)
|
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
| H00036 | Osteosarcoma |
P08684
(marker)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
| H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
| H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
| H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
| H00198 | Orotic aciduria |
P11172
(related)
|
| H00024 | Prostate cancer |
P11308
(related)
|
| H00035 | Ewing's sarcoma |
P11308
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
| H00038 | Malignant melanoma |
P14679
(marker)
|
| H00025 | Penile cancer |
P14780
(related)
P35354 (related) |
| H00479 | Metaphyseal dysplasias |
P14780
(related)
|
| H00808 | Idiopathic generalized epilepsies (IGEs) |
P14867
(related)
P18507 (related) |
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
| H01269 | Congenital hyperthyroidism |
P16473
(related)
|
| H00548 | Brunner syndrome |
P21397
(related)
|
| H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
P29973 (related) |
| H00769 | Hyperekplexia |
P23415
(related)
|
| H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
| H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00059 | Huntington's disease (HD) |
P42858
(related)
|
| H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
| H00094 | DNA repair defects |
P54132
(related)
|
| H00296 | Defects in RecQ helicases |
P54132
(related)
|
| H01257 | GABA-transaminase deficiency |
P80404
(related)
|
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
| H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
| H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
| H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
| H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
| H00720 | Long QT syndrome |
Q12809
(related)
|
| H00725 | Short QT syndrome |
Q12809
(related)
|
| H00971 | Achromatopsia |
Q16281
(related)
|
| H00208 | Hyperbilirubinemia |
Q92887
(related)
|
| H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|
| MESH or OMIM | name |
KNApSAcK
metabolite |
|---|---|---|
| D019970 | Cocaine-Related Disorders |
C00001337
C00019660 |
| D013375 | Substance Withdrawal Syndrome |
C00001337
C00019673 |
| D006973 | Hypertension |
C00001337
C00019673 |
| D012640 | Seizures |
C00001337
|
| D002389 | Catatonia |
C00001337
|
| D005693 | Galactosemias |
C00007391
|
| D064420 | Drug-Related Side Effects and Adverse Reactions |
C00001337
|
| D004827 | Epilepsy |
C00001337
|
| D006429 | Hemiplegia |
C00001337
|
| D001919 | Bradycardia |
C00001337
|
| D007022 | Hypotension |
C00001337
|
| D020149 | Manganese Poisoning |
C00001337
|
| D009069 | Movement Disorders |
C00001337
|
| D012559 | Schizophrenia |
C00001337
|
| D002375 | Catalepsy |
C00001337
|
| D013226 | Status Epilepticus |
C00001337
|
| D001259 | Ataxia |
C00001337
|
| D013610 | Tachycardia |
C00001337
|
| D004409 | Dyskinesia, Drug-Induced |
C00019673
|
| D006333 | Heart Failure |
C00019673
|
| D006930 | Hyperalgesia |
C00019673
|
| D008881 | Migraine Disorders |
C00019673
|
| D020326 | Migraine without Aura |
C00019673
|
| D048909 | Diabetes Complications |
C00001173
|
| D003929 | Diabetic Neuropathies |
C00001173
|
| D004660 | Encephalitis |
C00001173
|
| D010146 | Pain |
C00001173
|
| D010523 | Peripheral Nervous System Diseases |
C00001173
|
| D009410 | Nerve Degeneration |
C00019660
|